AlphaMark Advisors’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.11M | Sell |
12,183
-295
| -2% | -$30.3K | 0.48% | 46 |
|
|
2024
Q3 | $1.4M | Sell |
12,478
-529
| -4% | -$52.9K | 0.48% | 40 |
|
|
2024
Q2 | $1.27M | Sell |
13,007
-483
| -4% | -$47.9K | 0.44% | 39 |
|
|
2024
Q1 | $1.35M | Sell |
13,490
-23
| -0.2% | -$2.02K | 0.48% | 38 |
|
|
2023
Q4 | $1.21M | Buy |
13,513
+338
| +3% | +$26.9K | 0.46% | 41 |
|
|
2023
Q3 | $1.01M | Buy |
13,175
+457
| +4% | +$37.9K | 0.43% | 44 |
|
|
2023
Q2 | $1.06M | Buy |
12,718
+2,725
| +27% | +$222K | 0.49% | 46 |
|
|
2023
Q1 | $843K | Buy |
9,993
+2,310
| +30% | +$198K | 0.38% | 51 |
|
|
2022
Q4 | $626K | Buy |
7,683
+1
| +0% | +$81 | 0.31% | 57 |
|
|
2022
Q3 | $546K | Buy |
7,682
+159
| +2% | +$14.3K | 0.27% | 64 |
|
|
2022
Q2 | $675K | Buy |
7,523
+17
| +0.2% | +$1.76K | 0.31% | 58 |
|
|
2022
Q1 | $841K | Buy |
7,506
+23
| +0.3% | +$2.69K | 0.31% | 61 |
|
|
2021
Q4 | $905K | Sell |
7,483
-472
| -6% | -$52.5K | 0.32% | 65 |
|
|
2021
Q3 | $801K | Buy |
7,955
+156
| +2% | +$17.2K | 0.29% | 61 |
|
|
2021
Q2 | $911K | Sell |
7,799
-431
| -5% | -$51.7K | 0.33% | 57 |
|
|
2021
Q1 | $906K | Sell |
8,230
-935
| -10% | -$102K | 0.35% | 55 |
|
|
2020
Q4 | $919K | Sell |
9,165
-6,611
| -42% | -$613K | 0.35% | 53 |
|
|
2020
Q3 | $1.23M | Sell |
15,776
-3,670
| -19% | -$277K | 0.51% | 50 |
|
|
2020
Q2 | $1.35M | Buy |
19,446
+39
| +0.2% | +$2.46K | 0.58% | 39 |
|
|
2020
Q1 | $904K | Sell |
19,407
-9,785
| -34% | -$628K | 0.5% | 43 |
|
|
2019
Q4 | $2.31M | Buy |
29,192
+236
| +0.8% | +$18.1K | 0.97% | 40 |
|
|
2019
Q3 | $2.14M | Sell |
28,956
-709
| -2% | -$50.9K | 0.93% | 44 |
|
|
2019
Q2 | $2.31M | Buy |
29,665
+96
| +0.3% | +$7.29K | 1.01% | 42 |
|
|
2019
Q1 | $2.24M | Buy |
29,569
+335
| +1% | +$26.6K | 0.95% | 45 |
|
|
2018
Q4 | $2.14M | Buy |
29,234
+690
| +2% | +$55K | 1.03% | 44 |
|
|
2018
Q3 | $2.73M | Buy |
28,544
+197
| +0.7% | +$19.5K | 1.1% | 37 |
|
|
2018
Q2 | $2.83M | Buy |
28,347
+153
| +0.5% | +$16.2K | 1.15% | 38 |
|
|
2018
Q1 | $2.98M | Sell |
28,194
-2,056
| -7% | -$208K | 1.27% | 36 |
|
|
2017
Q4 | $2.8M | Sell |
30,250
-148
| -0.5% | -$13.4K | 1.1% | 38 |
|
|
2017
Q3 | $2.75M | Sell |
30,398
-1,667
| -5% | -$142K | 1.17% | 38 |
|
|
2017
Q2 | $2.69M | Buy |
32,065
+871
| +3% | +$70.2K | 1.15% | 38 |
|
|
2017
Q1 | $2.52M | Buy |
31,194
+461
| +2% | +$36.3K | 1.17% | 35 |
|
|
2016
Q4 | $2.31M | Sell |
30,733
-790
| -3% | -$57.1K | 1.19% | 34 |
|
|
2016
Q3 | $2.13M | Buy |
31,523
+1,865
| +6% | +$125K | 1.08% | 37 |
|
|
2016
Q2 | $2.01M | Sell |
29,658
-1,574
| -5% | -$116K | 1.19% | 36 |
|
|
2016
Q1 | $2.26M | Buy |
31,232
+356
| +1% | +$23.3K | 1.2% | 35 |
|
|
2015
Q4 | $2.08M | Sell |
30,876
-104
| -0.3% | -$7.28K | 1.06% | 34 |
|
|
2015
Q3 | $2M | Sell |
30,980
-148
| -0.5% | -$10.9K | 1.12% | 36 |
|
|
2015
Q2 | $2.55M | Buy |
31,128
+71
| +0.2% | +$5.47K | 1.43% | 31 |
|
|
2015
Q1 | $2.15M | Buy |
31,057
+400
| +1% | +$28.9K | 1.2% | 36 |
|
|
2014
Q4 | $2.33M | Buy |
30,657
+809
| +3% | +$64K | 1.44% | 33 |
|
|
2014
Q3 | $2.41M | Buy |
29,848
+577
| +2% | +$48.2K | 1.52% | 34 |
|
|
2014
Q2 | $2.56M | Sell |
29,271
-498
| -2% | -$43.3K | 1.52% | 31 |
|
|
2014
Q1 | $2.57M | Sell |
29,769
-76
| -0.3% | -$6.23K | 1.58% | 31 |
|
|
2013
Q4 | $2.41M | Sell |
29,845
-2,131
| -7% | -$165K | 1.5% | 30 |
|
|
2013
Q3 | $2.49M | Sell |
31,976
-445
| -1% | -$34.3K | 1.57% | 31 |
|
|
2013
Q2 | $2.27M | Buy |
+32,421
| New | +$2.26M | 1.38% | 35 |
|
Other funds holding EMN
AlphaMark Advisors's EMN Position: Q4 2024 in Review
AlphaMark Advisors reduced its Eastman Chemical (EMN) stake by 2.4% in Q4 2024, selling an estimated $30.3K and leaving 12,183 shares worth $1.11M. The position accounts for 0.48% of the portfolio, ranked #46.
AlphaMark Advisors first reported a position in EMN in Q2 2013 and has held it in 47 quarters since. The position peaked at $2.98M in Q1 2018. 786 funds tracked by Wall St. Rank hold EMN as of Q4 2024.
- AlphaMark Advisors held 12,183 shares of Eastman Chemical worth $1.11M as of Q4 2024.
- AlphaMark Advisors sold 295 Eastman Chemical shares in Q4 2024, an estimated $30.3K.
- Eastman Chemical made up 0.48% of AlphaMark Advisors's portfolio in Q4 2024, its #46 holding.
- AlphaMark Advisors first reported a position in Eastman Chemical in Q2 2013 and has held it in 47 quarters since.
- AlphaMark Advisors's Eastman Chemical position peaked at $2.98M in Q1 2018.
- 786 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2024.
Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.